Ultragenyx Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
18.02.26
/
50%
€17.40
Target price
18.02.27
€66.69
Performance (%)
9.28%
Price
05.06.26
€19.98
Summary
This prediction is currently active. With a performance of 9.28%, the BUY prediction by Canaccord_Genuity_Gr for Ultragenyx Pharmaceutical Inc. is trending in the right direction. This prediction currently runs until 18.02.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.818% | -1.818% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $128.00 to $79.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat